Added to YB: 2026-06-03
Pitch date: 2026-05-31
MEDP [bullish]
Medpace Holdings, Inc.
-0.19%
current return
Author Info
Sempiterno Investments shares deep dives into quality companies. Sign up for the newsletter.
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.9B
Pitch Price
$446.43
Price Target
N/A
Dividend
N/A
EV/EBITDA
19.52
P/E
28.39
EV/Sales
4.63
Sector
Life Sciences Tools and Services
Category
growth
New seeds planted - Medpace Holdings, Inc.
MEDP (new position): CRO providing clinical trial services to small/mid biotech. Founder-CEO August Troendle scaled to $2B+ rev organically, aggressive buybacks. Thesis: AI lowers R&D costs, improving economies of scale in high-fixed-cost industry & expanding drug development access for small cos—Medpace's niche. Still early in research.
Read full article (1 min)